<DOC>
	<DOCNO>NCT02588859</DOCNO>
	<brief_summary>This multicentre , non-interventional , prospective , observational study would conduct India understand usage effect saxagliptin first add-on therapy metformin . The study enroll Type 2 Diabetes Mellitus ( T2DM ) patient inadequately control metformin alone recently prescribe saxagliptin add-on metformin .</brief_summary>
	<brief_title>Study Understand Usage Effect Saxagliptin First Add-On After Metformin Indian Type 2 Diabetes Mellitus Patients</brief_title>
	<detailed_description>This multicentre , non-interventional , prospective , observational study would conduct India understand usage effect saxagliptin first add-on therapy metformin . The study enroll Type 2 Diabetes Mellitus ( T2DM ) patient inadequately control metformin alone recently ( i.e . within past 15 day ) prescribe saxagliptin add-on metformin . The Investigator/designee would get sign informed consent potential subject study . The patient meet inclusion none exclusion criterion enrol study . These patient assign patient identification number study . The Investigator/designee collect information per study schedule . This consider Visit 1 patient . The patient manage per routine clinical practice physician condition study neither interfere/advise Investigators/designee drug/medication prescribe patient prescribe intervention them.The enrolled patient would ask visit respective study sit 3 month ( +7 day ) Visit-2 study . Around 50 study center throughout India select goal enrol 1500 patient ( approximately 30 subject per site ) . The study initiate obtain write approval Independent/Institutional Ethics Committee write Informed consent patient .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Saxagliptin</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>1 . Patients willing provide informed consent . 2 . Female male patient age 18 year . 3 . Patients known case Type 2 diabetes mellitus . 4 . Patients inadequate glycaemic control take metformin monotherapy ( minimum dose 500 mg OD ) least 3 month . 5 . Patients recently ( last 15 day ) prescribe saxagliptin addition metformin . 1 . Patients Type 1 diabetes mellitus . 2 . Patients take glucose lower drug apart metformin saxagliptin . 3 . Any medical condition patient opinion Investigator would interfere safe completion study . 4 . Pregnant lactating woman . 5 . Women childbearing potential ready use effective barrier contraceptive method study .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>T2DM , Diabetes</keyword>
</DOC>